Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.

Clinical trial NCT06338644 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06338644
Sponsor: Helwan University
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Hormone-receptor-positive Breast Cancer Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Metastatic Breast Cancer

Start date: 2024-07-01
Primary completion: 2025-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.